Oxidation of Acetaminophen to Its Toxic Quinone Imine and Nontoxic Catechol Metabolites by Baculovirus-Expressed and Purified Human Cytochromes P450 2E1 and 2A6
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Acetaminophen (APAP), a widely used analgesic and antipyretic agent, is bioactivated by cytochromes P450 to cause severe hepatotoxicity. APAP is oxidized by two pathways to form a toxic intermediate, N-acetyl-p-benzoquinone imine (NAPQI), and a nontoxic catechol metabolite, 3-hydroxy-APAP (3-OH-APAP). We investigated the role of P450 2E1 and 2A6 in APAP oxidation by using baculovirus-expressed and highly purified forms of human P450 2E1 and 2A6. An electrochemical HPLC assay was developed to quantify both oxidative metabolites simultaneously. For the first time, it was demonstrated that human P450 2E1 selectively oxidized APAP to NAPQI (assayed as its glutathione conjugate, GS-APAP), whereas human P450 2A6 selectively oxidized APAP to 3-OH-APAP. At 1 mM APAP, the relative ratio for the formation of GS-APAP vs 3-OH-APAP with human P450 2E1 was approximately 6:1, whereas the ratio with human P450 2A6 was 1:3. Apparent Km and Vmax values for the formation of GS-APAP by human P450 2E1 were 1.3 mM and 6.9 nmol/min/nmol of P450, respectively, whereas they were 4.6 mM and 7.9 nmol/min/nmol of P450 for P450 2A6. Apparent Km and Vmax values for the formation of 3-OH-APAP by human P450 2E1 were 4.0 mM and 2.5 nmol/min/nmol of P450, respectively, whereas they were 2.2 mM and 14.2 nmol/min/nmol of P450, respectively, for P450 2A6. Thus, although at toxic doses of APAP P450 2E1 is the more efficient catalyst for the formation of the toxic metabolite NAPQI, P450 2A6 also can contribute significantly to NAPQI production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The remaining fraction, usually ranging from 5 to 15%, is oxidized by the CYP2E1, CYP1A2, CYP3A4, and CYP2A6 subfamilies of the P450 mixed-function oxidase system, resulting in the formation of N-acetyl-p-benzoquinoneimine (NAPQI) (50,62,159,211).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [50]
Citations
Cites
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
Cytochrome P450: Structure, mechanism, and biochemistry
Pryor, W. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)83807-x · Cited by 1,598
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Haining, R. L., Hunter, A. P., Veronese, M. E., Trager, W. F., & Rettie, A. E. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0414 · Cited by 249
Self-citationColes, B., Wilson, I., Wardman, P., Hinson, J. A., Nelson, S. D., & Ketterer, B. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90592-9 · Cited by 205
Self-citationHuman Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane Hepatitis
Bourdi, M., Chen, W., Peter, R. M., Martin, J. L., Buters, J. T. M., Nelson, S. D., & Pohl, L. R. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960083q · Cited by 189
Self-citationNelson, S. D. (1995) · Drug Metabolism Reviews · doi:10.3109/03602539509029821 · Cited by 183
Self-citationInhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans
Zand, R., Nelson, S. D., Slattery, J. T., Thummel, K. E., Kalhorn, T. F., Adams, S. P., & Wright, J. M. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.125 · Cited by 153
Self-citationHolme, J. A., Dahlin, D. C., Nelson, S. D., & Dybing, E. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90232-6 · Cited by 127
Self-citationThe complex interaction between ethanol and acetaminophen*
Slattery, J. T., Nelson, S. D., & Thummel, K. E. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90050-8 · Cited by 99
Self-citation
Research works printed but not linked: 36
- Hinson J. A., 1980, Rev. Biochem. Toxicol., 12
- Nelson S. D., 1990, Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Disease 10, 267−278
- Vermeulen N. P. E., 1992, Drug Metab. Rev., 24
- Prescott, L. F. (1996)Paracetamol(Acetaminophen)aCriticalBibliographicReview, pp 285−351, Taylor & Francis Ltd., London.
- Mitchell J. R., 1973, J. Pharmacol. Exp. Ther., 187
- Potter W. Z., 1973, J. Pharmacol. Exp. Ther., 187
- Corcoran G. B., 1984, N-acetyl-p-benzoquinone imine. Mol. Pharmacol. 18, 536−542.
- Dahlin D. C., 1984, Proc. Natl. Acad. Sci. U.S.A. 81
- Hinson J. A., 1980, 3-Hydroxyacetaminophen: A microsomal metabolite of acetaminophen. Drug Metab. Dispos. 8, 289−294
- Forte A. J., 1984, The formation and toxicity of catechol metabolites of acetaminophen in mice. Drug Metab. Dispos. 12, 484−491
- Guengerich F. P., 1991, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168−179
- Raucy J. L., 1989, Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys. 271, 270−283
- Patten C. J., 1993, Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 6, 511−518
- Lee S. S.-T., 1996, J. Biol. Chem., 271
- Burk R. F., 1990, Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it. Res. Commun. Chem. Pathol. Pharmacol. 69, 115−118
- Guengerich, F. P. (1995) InCytochromeP450:Structure,Mechanism,andBiochemistry, 2nd ed. (Ortiz de Montellano, P. R., Ed.) Chapter 14, p 485, Plenum Press, New York.
- Yamano S., 1990, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29, 1322−1329
- Yamazaki H., 1992, Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789−1794
- Duescher R. J., 1994, Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342−349
- Zhou L., 1997, J. Pharmacol. Exp. Ther., 281
- Chen W., 1996, Baculovirus expression and purification of human and rat cytochrome P450 2E1. Arch. Biochem. Biophys. 335, 123−130
- Thompson S. J., 1997, Baculovirus mediated expression, purification, and catalytic activity of human CYP2A6. Toxicologist 36 (Abstract 109), 22
- Shen A. L., 1991, J. Biol. Chem., 266
- Thummel K. E., 1993, Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug Metab. Dispos. 21, 350−357
- Koenigs L. L., 1997, Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab. Dispos. 25, 1407−1415
- Patten C. J., 1992, Catalytic properties of the human cytochrome P450 2E1 produced by cDNA expression in mammalian cells. Arch. Biochem. Biophys. 299, 163−171
- Peter R., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3, 566−573
- Wilkinson L., 1987, SYSTAT: The system for statistics
- Koop D. R., 1986, Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 29, 399−404
- Levin W., 1986, N-Demethylation of N-nitrosodimethylamine catalyzed by purified rat hepatic microsomal cytochrome P-450: isozyme specificity and role of cytochrome b5. Arch. Biochem. Biophys. 248, 158−165
- Myers T. G., 1995, A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3‘-hydroxyacetanilide. Chem. Res. Toxicol. 8, 403−411
- Halmes N. C., 1996, ISSX Proc., 10, 76
- Rumack B. H., 1978, Acetaminophen overdose: Incidence, diagnosis and management in 416 patients. Pediatrics 62, 898−903
- Ramsay R. P., 1989, vitro effects of acetaminophen metabolites and analogues on the respiration of mouse liver mitochondria. Arch. Biochem. Biophys. 273, 449−457
- Myers T. G., 1994, J. Med. Chem., 37
- Abbreviations APAP, acetaminophen
Cited by
ACETAMINOPHEN-INDUCED HEPATOTOXICITY
James, L. P., Mayeux, P. R., & Hinson, J. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1499 · Cited by 1,033
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Bessems, J. G. M., & Vermeulen, N. P. E. (2001) · Critical Reviews in Toxicology · doi:10.1080/20014091111677 · Cited by 715
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Larson, A. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.006 · Cited by 451
Methemoglobin—It's not just blue: A concise review
Umbreit, J. (2007) · American Journal of Hematology · doi:10.1002/ajh.20738 · Cited by 385
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses
Mazaleuskaya, L. L., Sangkuhl, K., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000150 · Cited by 379
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 359
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
MANYIKE, P., KHARASCH, E., KALHORN, T., & SLATTERY, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104736 · Cited by 355
Protective effect of rutin on paracetamol- and CCl4-induced hepatotoxicity in rodents
Janbaz, K. H., Saeed, S. A., & Gilani, A. H. (2002) · Fitoterapia · doi:10.1016/s0367-326x(02)00217-4 · Cited by 335
Nematollahi, D., Shayani-Jam, H., Alimoradi, M., & Niroomand, S. (2009) · Electrochimica Acta · doi:10.1016/j.electacta.2009.07.077 · Cited by 325
Hinson, J. A., Reid, A. B., McCullough, S. S., & James, L. P. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033494 · Cited by 306
Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes
Laine, J. E., Auriola, S., Pasanen, M., & Juvonen, R. O. (2009) · Xenobiotica · doi:10.1080/00498250802512830 · Cited by 262
Structures of Human Cytochrome P-450 2E1
Porubsky, P. R., Meneely, K. M., & Scott, E. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805999200 · Cited by 224
Paracetamol, alcohol and the liver
Prescott, L. F. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00167.x · Cited by 223
Role of drug metabolism in drug discovery and development
Kumar, G. N., & Surapaneni, S. (2001) · Medicinal Research Reviews · doi:10.1002/med.1016 · Cited by 201
Han, D., Dara, L., Win, S., Than, T. A., Yuan, L., Abbasi, S. Q., Liu, Z.-X., & Kaplowitz, N. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.009 · Cited by 196
Gilani, A. H., Jabeen, Q., Ghayur, M. N., Janbaz, K. H., & Akhtar, M. S. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.01.017 · Cited by 193
Brame, J., Long, M., Li, Q., & Alvarez, P. (2014) · Water Research · doi:10.1016/j.watres.2014.05.005 · Cited by 183
Reduction of Toxic Metabolite Formation of Acetaminophen
Hazai, E., Vereczkey, L., & Monostory, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6541 · Cited by 169
Senter, P. D., Al-Abed, Y., Metz, C. N., Benigni, F., Mitchell, R. A., Chesney, J., Han, J., Gartner, C. G., Nelson, S. D., Todaro, G. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011569399 · Cited by 166
Self-citationJanbaz, K. H., Saeed, S. A., & Gilani, A. H. (2004) · Phytomedicine · doi:10.1016/j.phymed.2003.05.002 · Cited by 165
Involvement of Human Cytochrome P450 2D6 in the Bioactivation of Acetaminophen
Dong, H., Haining, R. L., Thummel, K. E., Rettie, A. E., & Nelson, S. D. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)13665-3 · Cited by 130
Self-citationChen, C., Krausz, K. W., Idle, J. R., & Gonzalez, F. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706299200 · Cited by 143
Cheng, J., Ma, X., Krausz, K. W., Idle, J. R., & Gonzalez, F. J. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027565 · Cited by 148
Zhao, P., Kalhorn, T. F., & Slattery, J. T. (2002) · Hepatology · doi:10.1053/jhep.2002.34943 · Cited by 132
Paracetamol metabolism and related genetic differences
Zhao, L., & Pickering, G. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.527984 · Cited by 115
Cytochrome P450-Mediated Drug Interactions
Flockhart, D. A., & Oesterheld, J. R. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30135-4 · Cited by 129
Acetaminophen-induced liver injury: Molecular mechanism and treatments from natural products
Liao, J., Lu, Q., Li, Z., Li, J., Zhao, Q., & Li, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1122632 · Cited by 126
Disposition of Acetaminophen at 4, 6, and 8 g/day for 3 Days in Healthy Young Adults
Gelotte, C. K., Auiler, J. F., Lynch, J. M., Temple, A. R., & Slattery, J. T. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100121 · Cited by 116
Hepatotoxicity of the thiazolidinediones
Tolman, K. G., & Chandramouli, J. C. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00020-5 · Cited by 124
Mechanism-Based Inactivation of P450 2A6 by Furanocoumarins
Koenigs, L. L., & Trager, W. F. (1998) · Biochemistry · doi:10.1021/bi980003c · Cited by 118
Self-citationFoster, A. J., Chouhan, B., Regan, S. L., Rollison, H., Amberntsson, S., Andersson, L. C., Srivastava, A., Darnell, M., Cairns, J., Lazic, S. E., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02427-4 · Cited by 117
WANG, K., SHINDOH, H., INOUE, T., & HORII, I. (2002) · The Journal of Toxicological Sciences · doi:10.2131/jts.27.229 · Cited by 106
Role of CYP1A2 in the Hepatotoxicity of Acetaminophen: Investigations UsingCyp1a2Null Mice
Tonge, R. P., Kelly, E. J., Bruschi, S. A., Kalhorn, T. F., Eaton, D. L., Nebert, D. W., & Nelson, S. D. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8543 · Cited by 113
Self-citationA comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism
Chen, J., Jiang, S., Wang, J., Renukuntla, J., Sirimulla, S., & Chen, J. (2019) · Drug Metabolism Reviews · doi:10.1080/03602532.2019.1632889 · Cited by 106
Gan, J., Ruan, Q., He, B., Zhu, M., Shyu, W. C., & Humphreys, W. G. (2009) · Chemical Research in Toxicology · doi:10.1021/tx800368n · Cited by 102
Suzuki, H., Kneller, M. B., Haining, R. L., Trager, W. F., & Rettie, A. E. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.3.235 · Cited by 100
Self-citationInterspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes
Jemnitz, K., Veres, Z., Monostory, K., Kob́ori, L., & Vereczkey, L. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.02.001 · Cited by 99
Kwon, S. J., Lee, D. W., Shah, D. A., Ku, B., Jeon, S. Y., Solanki, K., Ryan, J. D., Clark, D. S., Dordick, J. S., & Lee, M.-Y. (2014) · Nature Communications · doi:10.1038/ncomms4739 · Cited by 95
The Biochemistry of Drug Metabolism – An Introduction: Part 5. Metabolism and Bioactivity
Testa, B., & Krämer, S. D. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900022 · Cited by 91
Rendic, S. P., & Guengerich, F. P. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02971-4 · Cited by 88
The Molecular Toxicology of Acetaminophen
Josephy, P. D. (2005) · Drug Metabolism Reviews · doi:10.1080/03602530500205200 · Cited by 80
Chen, W., Shockcor, J. P., Tonge, R., Hunter, A. S., Gartner, C. G., & Nelson, S. D. (1999) · Biochemistry · doi:10.1021/bi990125k · Cited by 78
Self-citationBaer, B. R., Rettie, A. E., & Henne, K. R. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0496993 · Cited by 76
Self-citationChemical toxicology: reactive intermediates and their role in pharmacology and toxicology
Erve, J. C. L. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.923 · Cited by 74
Dargan, P. I., Kalsi, Wood, D. M., & Waring (2011) · Open Access Emergency Medicine · doi:10.2147/oaem.s24962 · Cited by 73
The role of MAP2 kinases and p38 kinase in acute murine liver injury models
Zhang, J., Min, R. W. M., Le, K., Zhou, S., Aghajan, M., Than, T. A., Win, S., & Kaplowitz, N. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.295 · Cited by 73
Ladumor, M. K., Bhatt, D. K., Gaedigk, A., Sharma, S., Thakur, A., Pearce, R. E., Leeder, J. S., Bolger, M. B., Singh, S., & Prasad, B. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086462 · Cited by 70
Weigt, S., Hübler, N., Braunbeck, T. A., von Landenberg, F., & Broschard, T. H. (2010) · Toxicology · doi:10.1016/j.tox.2010.05.012 · Cited by 67
Mingoia, R. T., Nabb, D. L., Yang, C., & Han, X. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.10.012 · Cited by 66
Cameron, M. D., Wen, B., Allen, K. E., Roberts, A. G., Schuman, J. T., Campbell, A. P., Kunze, K. L., & Nelson, S. D. (2005) · Biochemistry · doi:10.1021/bi051689t · Cited by 66
Self-citationStructural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes
Bart, A. G., & Scott, E. E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000220 · Cited by 64
Kikkawa, R., Yamamoto, T., Fukushima, T., Yamada, H., & Horii, I. (2005) · The Journal of Toxicological Sciences · doi:10.2131/jts.30.61 · Cited by 64
Ochoa, J. G. D., Bucher, J., Péry, A. R. R., Comenges, J. M. Z., Niklas, J., & Mauch, K. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00204 · Cited by 63
Gao, Q., Doneanu, C. E., Shaffer, S. A., Adman, E. T., Goodlett, D. R., & Nelson, S. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601785200 · Cited by 60
Self-citationFunctional characterisation of an engineered multidomain human P450 2E1 by molecular Lego
Fairhead, M., Giannini, S., Gillam, E. M. J., & Gilardi, G. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0033-1 · Cited by 59
Jaeschke, H., Murray, F. J., Monnot, A. D., Jacobson‐Kram, D., Cohen, S. M., Hardisty, J. F., Atillasoy, E. O., Hermanowski‐Vosatka, A., Kuffner, E. K., Wikoff, D. S., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104859 · Cited by 58
Cell culture model for acetaminophen-induced hepatocyte death in vivo
Pierce, R. H., Franklin, C. C., Campbell, J. S., Tonge, R. P., Chen, W., Fausto, N., Nelson, S. D., & Bruschi, S. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01180-2 · Cited by 57
Self-citationOptimising the management of fever and pain in children
van den Anker, J. N. (2012) · International Journal of Clinical Practice · doi:10.1111/ijcp.12056 · Cited by 56
Fılık, H., Çetintaş, G., Avan, A. A., Koç, S. N., & Boz, İ. (2013) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)14718-3 · Cited by 55
Cooperative Binding of Acetaminophen and Caffeine within the P450 3A4 Active Site
Cameron, M. D., Wen, B., Roberts, A. G., Atkins, W. M., Campbell, A. P., & Nelson, S. D. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7000702 · Cited by 53
Self-citationSingle-Dose Methoxsalen Effects on Human Cytochrome P-450 2A6 Activity
Kharasch, E. D., Hankins, D. C., & Taraday, J. K. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14998-7 · Cited by 53
Garai, J., & Lóránd, T. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581842 · Cited by 52
Karthivashan, G., Arulselvan, P., Tan, S. W., & Fakurazi, S. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.05.007 · Cited by 52
Grespan, R., Aguiar, R. P., Giubilei, F. N., Fuso, R. R., Damião, M. J., Silva, E. L., Mikcha, J. M. G., Hernandes, L., Amado, C. B., & Cuman, R. K. N. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/954136 · Cited by 51
Cao, L., Kwara, A., & Greenblatt, D. J. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12812 · Cited by 51
Biotransformations Leading to Toxic Metabolites
Macherey, A., & Dansette, P. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374194-3.00033-0 · Cited by 50
Brown, J. M., Ball, J. G., Wright, M. S., Meter, S. V., & Valentovic, M. A. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.05.018 · Cited by 50
A Risk-Benefit Assessment of Paracetamol (Acetaminophen) Combined with Caffeine
Palmer, H., Graham, G. G., Williams, K. M., & Day, R. O. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00867.x · Cited by 49
McDonald, M. G., Ray, S., Amorosi, C. J., Sitko, K. A., Kowalski, J. P., Paço, L., Nath, A., Gallis, B. M., Totah, R. A., Dunham, M. J., et al. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078188 · Cited by 47
Self-citationParameswari, S., Chetty, C. M., & Chandrasekhar, K. (2013) · Pharmacognosy Research · doi:10.4103/0974-8490.118828 · Cited by 46
Microsomal oxidative damage promoted by acetaminophen metabolism
Letelier, M. E., López-Valladares, M., Peredo-Silva, L., Rojas-Sepúlveda, D., & Aracena-Parks, P. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.04.022 · Cited by 45
Wang, J.-X., Zhang, C., Fu, L., Zhang, D.-G., Wang, B.-W., Zhang, Z., Chen, Y., Lü, Y., Chen, X., & Xu, D. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.012 · Cited by 44
Tanaka, E., Yamazaki, K., & Misawa, S. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00301.x · Cited by 43
Monostory, K., Hazai, E., & Vereczkey, L. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.03.003 · Cited by 43
Zhao, C., Gao, Q., Roberts, A. G., Shaffer, S. A., Doneanu, C. E., Xue, S., Goodlett, D. R., Nelson, S. D., & Atkins, W. M. (2012) · Biochemistry · doi:10.1021/bi301069r · Cited by 42
Self-citationShumyantseva, V. V., Bulko, T. V., Kuzikov, A. V., Masamrekh, R. A., Konyakhina, A. Y., Romanenko, I., Max, J. B., Köhler, M., Gilep, A. A., Usanov, S. A., et al. (2020) · Electrochimica Acta · doi:10.1016/j.electacta.2019.135579 · Cited by 42
Eom, S., Zhang, Y. W., Kim, S., Choe, K., Lee, K. Y., Park, J., Hong, Y., Kim, Y., Kang, J., & Kim, H. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9225-7 · Cited by 42
Lewis, D. F. V., Lake, B. G., Bird, M. G., Loizou, G. D., Dickins, M., & Goldfarb, P. S. (2003) · Toxicology in Vitro · doi:10.1016/s0887-2333(02)00098-x · Cited by 42
Natural Products for Acetaminophen-Induced Acute Liver Injury: A Review
Li, X., Lao, R., Lei, J., Chen, Y., Zhou, Q., Wang, T., & Tong, Y. (2023) · Molecules · doi:10.3390/molecules28237901 · Cited by 41
Wang, Y., Du, Y., Xia-Fei, L. I. U., Yang, F.-X., Xiao, W. U., Tan, L., Lu, Y., Zhang, J., Zhou, F., & Wang, G. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30073-1 · Cited by 39
Marks, B. D., Smith, R. W., Braun, H. A., Goossens, T. A., Christenson, M. J., Ozers, M. S., Lebakken, C. S., & Trubetskoy, O. V. (2002) · Assay and Drug Development Technologies · doi:10.1089/154065802761001329 · Cited by 39
Structural Alerts for Toxicity
Blagg, J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc128 · Cited by 39
Fulminant Hepatitis After 10 Days of Acetaminophen Treatment at Recommended Dosage in an Infant
Savino, F., Lupica, M. M., Tarasco, V., Locatelli, E., Garazzino, S., & Tovo, P. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1965 · Cited by 38
Yang, Y., Wong, S., & Lightstone, F. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087058 · Cited by 37
High-content imaging assays on a miniaturized 3D cell culture platform
Joshi, P., Datar, A., Yu, K., Kang, S., & Lee, M. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.02.014 · Cited by 37
Lee, J. H., Suh, O. K., & Lee, M. G. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980136 · Cited by 36
Wen, B., Doneanu, C. E., Gartner, C. A., Roberts, A. G., Atkins, W. M., & Nelson, S. D. (2005) · Biochemistry · doi:10.1021/bi048228c · Cited by 34
Self-citationPingili, R. B., Pawar, A. K., & Challa, S. R. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.014 · Cited by 34
Yamazoe, Y., Ito, K., & Yoshinari, K. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.624103 · Cited by 34
Nasal Cytotoxic and Carcinogenic Activities of Systemically Distributed Organic Chemicals
Jeffrey, A. M., Iatropoulos, M. J., & Williams, G. M. (2006) · Toxicologic Pathology · doi:10.1080/01926230601042494 · Cited by 34
Biotransformations Leading to Toxic Metabolites
Macherey, A., & Dansette, P. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417205-0.00025-0 · Cited by 31
Lai, W. G., Gardner, I. B., ZAHID, N. D., & Uetrecht, J. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15359-7 · Cited by 31
Saikrithika, S., & Kumar, A. S. (2023) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.3c00307 · Cited by 30
Timescale analysis of a mathematical model of acetaminophen metabolism and toxicity
Reddyhoff, D., Ward, J., Williams, D. P., Regan, S., & Webb, S. D. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.08.021 · Cited by 30
Dargan, P. I., & Jones, A. L. (2002) · Drug Safety · doi:10.2165/00002018-200225090-00002 · Cited by 30
Sharmin, R., Nusantara, A. C., Nie, L., Wu, K., Elías-Llumbet, A., Woudstra, W., Mzyk, A., & Schirhagl, R. (2022) · ACS Sensors · doi:10.1021/acssensors.2c01272 · Cited by 29
Lewis, D. F. V., Lake, B. G., & M. Dickins (2004) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2004.20.3.111 · Cited by 29
Antunes, A. M. M., Novais, D. A., da Silva, J. F., Santos, P. P., Oliveira, M. C., Beland, F. A., & Marques, M. M. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob06052j · Cited by 28
Metadata
- Authors
- Chen, W., Koenigs, L. L., Thompson, S. J., Peter, R. M., Rettie, A. E., Trager, W. F., & Nelson, S. D.
- Affiliations
- University of Washington (US)
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 1998-02-27
- Volume
- 11
- Issue
- 4
- Pages
- 295-301
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2050204181
- Cited by
- 226
- References
- 14
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 2 · 2023: 7 · 2022: 5 · 2021: 6 · 2020: 9 · 2019: 11 · 2018: 12 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 8 · 2013: 8 · 2012: 10
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM049054, GM32165, P01GM032165, GM49054)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- paracetamol, N-acetyl-p-benzoquinone imine, CYP2E1, CYP2A6, hepatotoxicity, glutathione conjugates, enzyme kinetics, substrate specificity
- MeSH terms
- Acetaminophen, Aryl Hydrocarbon Hydroxylases, Cytochrome P-450 Enzyme System, Humans, Mixed Function Oxygenases, Baculoviridae, Analgesics, Non-Narcotic, Cytochrome P-450 CYP2E1, Cytochrome P-450 CYP2A6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.